L-ARGININE

L-ARGININE was reported 359 times

L-ARGININE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD AMINO ACID LEVEL DECREASED 1 0.3333
1 ACQUIRED MITOCHONDRIAL DNA MUTATION 2 0.1538
2 CULTURE URINE NEGATIVE 1 0.0909
3 PERICARDIAL NEOPLASM 1 0.0769
4 HYPERAMMONAEMIC CRISIS 6 0.0561
5 OESOPHAGEAL PAPILLOMA 1 0.0385
6 SYSTEMIC-PULMONARY ARTERY SHUNT 1 0.0312
7 PNEUMOCYSTIS CARINII INFECTION 1 0.0270
8 CYSTIC FIBROSIS PANCREATIC 1 0.0222
9 BALLOON ATRIAL SEPTOSTOMY 1 0.0208
10 UTERINE ATROPHY 1 0.0137
11 PULMONARY VASCULAR RESISTANCE ABNORMALITY 1 0.0116
12 PULMONARY ARTERIAL PRESSURE DECREASED 1 0.0109
13 CRYPTOGENIC ORGANIZING PNEUMONIA 2 0.0104
14 FAILED INDUCTION OF LABOUR 2 0.0103
15 MELAS SYNDROME 2 0.0093
16 ADRENAL CYST 1 0.0091
17 IMPAIRED INSULIN SECRETION 1 0.0085
18 CONGENITAL NAEVUS 1 0.0070
19 ENDOMETRIAL ATROPHY 1 0.0069
20 RENAL CANCER RECURRENT 1 0.0068
21 OESOPHAGEAL POLYP 1 0.0053
22 GENITAL DISORDER MALE 1 0.0047
23 PARANASAL SINUS INFLAMMATION 1 0.0045
24 TRAUMATIC LIVER INJURY 1 0.0043
25 PENILE HAEMATOMA 1 0.0043
26 ANAPLASTIC LARGE-CELL LYMPHOMA 1 0.0042
27 CERVICAL CYST 1 0.0042
28 DISEASE SUSCEPTIBILITY 1 0.0036
29 ENAMEL ANOMALY 1 0.0035
30 PULMONARY ARTERIAL PRESSURE ABNORMAL 1 0.0035
31 MALOCCLUSION 1 0.0034
32 BLOOD OESTROGEN INCREASED 2 0.0034
33 SCARLET FEVER 1 0.0031
34 AMINO ACID LEVEL DECREASED 1 0.0030
35 HYPOGONADISM 3 0.0030
36 ANDROGEN DEFICIENCY 1 0.0028
37 ECLAMPSIA 1 0.0027
38 IMPAIRED REASONING 1 0.0026
39 MITOCHONDRIAL TOXICITY 2 0.0024
40 HYPERAMMONAEMIA 12 0.0024
41 CORONARY ARTERY ATHEROSCLEROSIS 1 0.0024
42 TRANSFERRIN SATURATION DECREASED 1 0.0023
43 MOTOR NEURONE DISEASE 1 0.0021
44 APPLICATION SITE INFECTION 1 0.0020
45 PLEURAL FIBROSIS 2 0.0020
46 PHYSIOTHERAPY 1 0.0019
47 TOBACCO ABUSE 1 0.0019
48 BURSITIS INFECTIVE 1 0.0018
49 INTERTRIGO 1 0.0018
50 LIFE SUPPORT 1 0.0018
51 MOTOR DEVELOPMENTAL DELAY 1 0.0017
52 PROTRUSION TONGUE 1 0.0017
53 CERVICOBRACHIAL SYNDROME 1 0.0016
54 CORTISOL INCREASED 1 0.0016
55 ENDOMETRIAL ADENOCARCINOMA 1 0.0016
56 PREMATURE EJACULATION 1 0.0016
57 EMERGENCY CARE EXAMINATION 1 0.0015
58 BLOOD OESTROGEN DECREASED 1 0.0014
59 MYOFASCIAL PAIN SYNDROME 1 0.0014
60 AMMONIA INCREASED 7 0.0014
61 OTITIS MEDIA ACUTE 1 0.0014
62 GRIMACING 1 0.0013
63 FOETAL GROWTH RETARDATION 1 0.0013
64 INTERVERTEBRAL DISC SPACE NARROWING 1 0.0012
65 ENDOMETRIAL HYPERPLASIA 1 0.0012
66 MYCOSIS FUNGOIDES 1 0.0012
67 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
68 ADRENAL MASS 1 0.0012
69 HEPATIC HAEMORRHAGE 1 0.0012
70 TESTICULAR ATROPHY 1 0.0011
71 LOW BIRTH WEIGHT BABY 9 0.0011
72 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
73 PENILE SIZE REDUCED 1 0.0011
74 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
75 APPLICATION SITE BRUISE 1 0.0010
76 GASTRECTOMY 1 0.0010
77 REDUCED FACIAL EXPRESSION 1 0.0010
78 FEEDING DISORDER NEONATAL 1 0.0010
79 INTRACRANIAL VENOUS SINUS THROMBOSIS 1 0.0009
80 LYMPHOCYTOSIS 2 0.0009
81 HAEMOGLOBINURIA 1 0.0009
82 GASTROINTESTINAL ULCER HAEMORRHAGE 1 0.0009
83 ORAL PRURITUS 2 0.0009
84 CARBON DIOXIDE DECREASED 1 0.0009
85 ESCHERICHIA TEST POSITIVE 1 0.0008
86 PENILE SWELLING 1 0.0008
87 PANCREATIC NEOPLASM 1 0.0008
88 MALLORY-WEISS SYNDROME 1 0.0008
89 SEDATION COMPLICATION 2 0.0008
90 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
91 ENDOCRINE DISORDER 1 0.0008
92 APPLICATION SITE EROSION 1 0.0008
93 LIBIDO DISORDER 1 0.0008
94 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
95 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
96 ANION GAP INCREASED 1 0.0007
97 BLOOD TESTOSTERONE DECREASED 5 0.0007
98 CHRONIC FATIGUE SYNDROME 1 0.0007
99 DIABETIC FOOT INFECTION 1 0.0007
100 JUDGEMENT IMPAIRED 1 0.0007
101 GENERALISED ANXIETY DISORDER 1 0.0007
102 NEPHRECTOMY 1 0.0007
103 INFERTILITY 1 0.0007
104 ASTIGMATISM 1 0.0007
105 INTELLECTUAL DISABILITY 1 0.0007
106 PENILE PAIN 2 0.0007
107 INFERTILITY FEMALE 1 0.0006
108 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
109 PULMONARY ARTERIAL PRESSURE INCREASED 1 0.0006
110 OXYGEN THERAPY 1 0.0006
111 SPINAL CORD DISORDER 1 0.0006
112 SPINAL DEFORMITY 1 0.0006
113 FOOD AVERSION 1 0.0006
114 DEAFNESS BILATERAL 1 0.0006
115 REGURGITATION 2 0.0006
116 MYCOBACTERIAL INFECTION 1 0.0006
117 TONGUE COATED 1 0.0006
118 GRANULOMA 2 0.0006
119 FOOD INTERACTION 1 0.0006
120 UTERINE POLYP 1 0.0006
121 DEVICE ALARM ISSUE 1 0.0006
122 LIVER TRANSPLANT 2 0.0005
123 HYPERSEXUALITY 1 0.0005
124 SINUS NODE DYSFUNCTION 1 0.0005
125 OESOPHAGEAL SPASM 1 0.0005
126 OTOTOXICITY 1 0.0005
127 OPPORTUNISTIC INFECTION 1 0.0005
128 PANCREATIC CYST 1 0.0005
129 ADRENAL DISORDER 1 0.0005
130 ATROPHY 1 0.0005
131 NASAL SEPTUM DEVIATION 1 0.0005
132 UNDERWEIGHT 1 0.0005
133 EJACULATION FAILURE 1 0.0005
134 SELF-MEDICATION 2 0.0005
135 SLEEP DEFICIT 1 0.0005
136 BLOOD TESTOSTERONE INCREASED 1 0.0005
137 LANGUAGE DISORDER 1 0.0005
138 OESOPHAGEAL VARICES HAEMORRHAGE 1 0.0005
139 GASTRIC BYPASS 1 0.0005
140 CLOSTRIDIUM TEST POSITIVE 1 0.0005
141 GASTROINTESTINAL ULCER 1 0.0005
142 HAEMATOCRIT INCREASED 1 0.0004
143 DISLOCATION OF VERTEBRA 1 0.0004
144 LICHEN PLANUS 1 0.0004
145 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
146 ESCHERICHIA BACTERAEMIA 1 0.0004
147 URINARY HESITATION 1 0.0004
148 DIABETES INSIPIDUS 1 0.0004
149 PENIS DISORDER 1 0.0004
150 VASODILATATION 1 0.0004
151 MEDICATION RESIDUE 1 0.0004
152 LIPOMA 1 0.0004
153 YAWNING 1 0.0004
154 SHOULDER ARTHROPLASTY 1 0.0004
155 GAMBLING DISORDER 1 0.0004
156 CHONDROPATHY 1 0.0004
157 TENOSYNOVITIS 1 0.0004
158 INJECTION SITE SCAR 1 0.0004
159 UPPER RESPIRATORY TRACT CONGESTION 1 0.0003
160 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
161 SINUS HEADACHE 2 0.0003
162 BRAIN HERNIATION 1 0.0003
163 URINE ANALYSIS ABNORMAL 1 0.0003
164 BLOOD CULTURE POSITIVE 1 0.0003
165 LOSS OF LIBIDO 3 0.0003
166 PREMATURE BABY 10 0.0003
167 LOSS OF EMPLOYMENT 1 0.0003
168 CRANIOCEREBRAL INJURY 1 0.0003
169 KERATITIS 1 0.0003
170 MASTICATION DISORDER 1 0.0003
171 INTRACARDIAC THROMBUS 1 0.0003
172 PRE-EXISTING CONDITION IMPROVED 2 0.0003
173 RESPIRATORY RATE DECREASED 1 0.0003
174 NON-CARDIAC CHEST PAIN 1 0.0003
175 POSTURE ABNORMAL 1 0.0003
176 THROMBOSIS IN DEVICE 1 0.0003
177 WALKING AID USER 2 0.0003
178 THERAPEUTIC AGENT TOXICITY 1 0.0003
179 DIABETIC RETINOPATHY 1 0.0003
180 HYPOPNOEA 1 0.0003
181 RIGHT VENTRICULAR FAILURE 2 0.0003
182 HANGOVER 1 0.0003
183 BRONCHIOLITIS 1 0.0003
184 LUNG TRANSPLANT 1 0.0003
185 PARADOXICAL DRUG REACTION 1 0.0003
186 TENDON INJURY 1 0.0003
187 HYPERACUSIS 1 0.0003
188 SUNBURN 2 0.0003
189 STATUS EPILEPTICUS 3 0.0003
190 PARANASAL SINUS DISCOMFORT 1 0.0003
191 LOSS OF CONTROL OF LEGS 1 0.0003
192 PARANASAL SINUS HYPERSECRETION 1 0.0003
193 THYROID MASS 1 0.0003
194 CONCUSSION 2 0.0003
195 SPINAL CORD COMPRESSION 1 0.0003
196 MUSCLE RUPTURE 1 0.0003
197 SKIN ODOUR ABNORMAL 1 0.0003
198 AZOTAEMIA 1 0.0003
199 ENURESIS 1 0.0002
200 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
201 SOCIAL PROBLEM 1 0.0002
202 THYROID FUNCTION TEST ABNORMAL 1 0.0002
203 BRAIN OEDEMA 3 0.0002
204 ERECTILE DYSFUNCTION 6 0.0002
205 TONGUE DISCOLOURATION 1 0.0002
206 WHEELCHAIR USER 1 0.0002
207 DRUG EFFECT DELAYED 1 0.0002
208 ISCHAEMIA 1 0.0002
209 UROSEPSIS 2 0.0002
210 SYNOVIAL CYST 1 0.0002
211 NEPHROGENIC ANAEMIA 1 0.0002
212 ARTHRITIS INFECTIVE 1 0.0002
213 FEELING OF DESPAIR 1 0.0002
214 DIALYSIS 3 0.0002
215 PARALYSIS 3 0.0002
216 LIMB OPERATION 1 0.0002
217 TUMOUR MARKER INCREASED 1 0.0002
218 PANCREATIC DISORDER 1 0.0002
219 SMALL FOR DATES BABY 1 0.0002
220 ABDOMINAL TENDERNESS 1 0.0002
221 HYPERNATRAEMIA 1 0.0002
222 PETIT MAL EPILEPSY 1 0.0002
223 INITIAL INSOMNIA 2 0.0002
224 PRODUCT COLOUR ISSUE 1 0.0002
225 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
226 SUDDEN DEATH 2 0.0002
227 PREMATURE DELIVERY 3 0.0002
228 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
229 GINGIVITIS 1 0.0002
230 STRESS FRACTURE 1 0.0002
231 JAW DISORDER 1 0.0002
232 DEAFNESS UNILATERAL 1 0.0002
233 STREPTOCOCCAL INFECTION 1 0.0002
234 NECROSIS 1 0.0002
235 INTRACRANIAL PRESSURE INCREASED 1 0.0002
236 ANGIOPATHY 1 0.0002
237 PREMATURE LABOUR 1 0.0002
238 SKIN ATROPHY 1 0.0002
239 HYPERVENTILATION 1 0.0002
240 METABOLIC DISORDER 1 0.0002
241 CAESAREAN SECTION 2 0.0002
242 HYPERTRIGLYCERIDAEMIA 1 0.0002
243 HYPERCHLORHYDRIA 1 0.0002
244 NOCTURIA 2 0.0002
245 DRUG ABUSER 1 0.0002
246 NASAL DRYNESS 1 0.0002
247 PHOTOPHOBIA 3 0.0002
248 BLEPHAROSPASM 1 0.0002
249 PHOTOPSIA 1 0.0002
250 THERAPEUTIC RESPONSE CHANGED 1 0.0002
251 PRODUCT PREPARATION ISSUE 1 0.0002
252 TERMINAL STATE 1 0.0001
253 POST-TRAUMATIC STRESS DISORDER 1 0.0001
254 QUALITY OF LIFE DECREASED 2 0.0001
255 SINUS CONGESTION 2 0.0001
256 IMPAIRED GASTRIC EMPTYING 2 0.0001
257 ABNORMAL LOSS OF WEIGHT 1 0.0001
258 CORONARY ARTERY OCCLUSION 2 0.0001
259 JOINT EFFUSION 1 0.0001
260 EXTRASYSTOLES 1 0.0001
261 MASS 2 0.0001
262 CARPAL TUNNEL SYNDROME 2 0.0001
263 THERMAL BURN 1 0.0001
264 RETINAL HAEMORRHAGE 1 0.0001
265 PRODUCT SUPPLY ISSUE 1 0.0001
266 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
267 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
268 MAJOR DEPRESSION 1 0.0001
269 UTERINE LEIOMYOMA 1 0.0001
270 PSYCHOTIC DISORDER 4 0.0001
271 TRANSAMINASES INCREASED 3 0.0001
272 ECONOMIC PROBLEM 2 0.0001
273 BOWEL MOVEMENT IRREGULARITY 1 0.0001
274 MATERNAL DRUGS AFFECTING FOETUS 1 0.0001
275 HAEMOLYSIS 1 0.0001
276 DELUSION 2 0.0001
277 HAEMORRHAGIC STROKE 1 0.0001
278 PULMONARY HAEMORRHAGE 1 0.0001
279 MULTIPLE ALLERGIES 1 0.0001
280 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
281 BLOOD ALBUMIN DECREASED 1 0.0001
282 RENAL CYST 1 0.0001
283 LOCALISED INFECTION 3 0.0001
284 RHINITIS 1 0.0001
285 FRUSTRATION TOLERANCE DECREASED 1 0.0001
286 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
287 BACK DISORDER 2 0.0001
288 HICCUPS 1 0.0001
289 ABASIA 3 0.0001
290 EMBOLISM 1 0.0001
291 HAEMODIALYSIS 1 0.0001
292 SPINAL OSTEOARTHRITIS 1 0.0001
293 RESPIRATORY RATE INCREASED 1 0.0001
294 GASTROINTESTINAL INFECTION 1 0.0001
295 DEVELOPMENTAL DELAY 1 0.0001
296 RESTLESS LEGS SYNDROME 2 0.0001
297 END STAGE RENAL DISEASE 2 0.0001
298 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
299 PNEUMONIA BACTERIAL 1 0.0001
300 BRAIN NEOPLASM 1 0.0001
301 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
302 ABNORMAL DREAMS 3 0.0001
303 NERVE COMPRESSION 1 0.0001
304 BREAST CANCER STAGE I 1 0.0001
305 LACERATION 1 0.0001
306 DYSARTHRIA 4 0.0001
307 ARTERIOSCLEROSIS 1 0.0001
308 SQUAMOUS CELL CARCINOMA 1 0.0001
309 LEUKAEMIA 1 0.0001
310 SPUTUM DISCOLOURED 1 0.0001
311 RECALLED PRODUCT ADMINISTERED 1 0.0001
312 PULMONARY FIBROSIS 2 0.0001
313 POST PROCEDURAL COMPLICATION 2 0.0001
314 AFFECT LABILITY 1 0.0001
315 AUTOIMMUNE DISORDER 1 0.0001
316 VITAMIN D DEFICIENCY 1 0.0001
317 COELIAC DISEASE 1 0.0001
318 VITREOUS FLOATERS 1 0.0001
319 DISORIENTATION 4 0.0001
320 OVARIAN CYST 1 0.0001
321 SALIVARY HYPERSECRETION 1 0.0001
322 TOXIC SKIN ERUPTION 1 0.0001
323 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
324 TEMPERATURE INTOLERANCE 1 0.0001
325 WEIGHT FLUCTUATION 1 0.0001
326 MUSCULOSKELETAL PAIN 5 0.0001
327 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
328 SCRATCH 1 0.0001
329 JOINT DISLOCATION 1 0.0001
330 RENAL PAIN 1 0.0001
331 BODY HEIGHT DECREASED 1 0.0001
332 POOR QUALITY SLEEP 2 0.0001
333 DRUG EFFECT DECREASED 5 0.0001
334 BALANCE DISORDER 8 0.0001
335 BACK INJURY 1 0.0001
336 OESOPHAGITIS 1 0.0001
337 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
338 NERVE INJURY 1 0.0001
339 SNEEZING 2 0.0001
340 CHROMATURIA 2 0.0001
341 MITRAL VALVE INCOMPETENCE 1 0.0001
342 CHOLECYSTECTOMY 1 0.0001
343 INTERNAL HAEMORRHAGE 1 0.0001
344 TINNITUS 4 0.0001
345 ELECTROLYTE IMBALANCE 1 0.0001
346 SEXUAL DYSFUNCTION 1 0.0001
347 ATAXIA 1 0.0001
348 DRUG EFFECT INCOMPLETE 3 0.0001
349 NEURALGIA 2 0.0001
350 NO THERAPEUTIC RESPONSE 1 0.0001
351 RESTLESSNESS 3 0.0001
352 SPINAL OPERATION 1 0.0001
353 TOOTH EXTRACTION 1 0.0001
354 INJECTION SITE DISCOLOURATION 1 0.0001
355 SECRETION DISCHARGE 1 0.0001
356 DYSPNOEA EXERTIONAL 3 0.0001
357 UNEVALUABLE EVENT 6 0.0001
358 MUSCLE ATROPHY 1 0.0001
359 SINUSITIS 8 0.0001
360 THERAPY CESSATION 4 0.0001
361 ROTATOR CUFF SYNDROME 1 0.0001
362 RESPIRATORY TRACT INFECTION 2 0.0001
363 NODULE 1 0.0001
364 SEDATION 2 0.0001
365 HAIR TEXTURE ABNORMAL 1 0.0001
366 CONFUSIONAL STATE 12 0.0001
367 AKATHISIA 1 0.0001
368 PERIPHERAL COLDNESS 1 0.0001
369 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
370 COORDINATION ABNORMAL 1 0.0001
371 INSOMNIA 19 0.0001
372 DEVICE OCCLUSION 1 0.0001
373 BRONCHOSPASM 1 0.0001
374 SUBDURAL HAEMATOMA 1 0.0001
375 HYPERSOMNIA 2 0.0001
376 CARDIOGENIC SHOCK 1 0.0001
377 IMPAIRED QUALITY OF LIFE 1 0.0001
378 LETHARGY 4 0.0001
379 PARAESTHESIA ORAL 1 0.0001
380 HYPOKINESIA 1 0.0001
381 APATHY 1 0.0001
382 GASTROENTERITIS 1 0.0001
383 WHEEZING 4 0.0001
384 RENAL INJURY 2 0.0001
385 IMMUNODEFICIENCY 1 0.0001
386 BONE LOSS 1 0.0001
387 APHASIA 2 0.0001
388 PHARYNGEAL OEDEMA 1 0.0001
389 MUSCULOSKELETAL CHEST PAIN 1 0.0001
390 TENDONITIS 1 0.0001
391 BLOOD CHOLESTEROL INCREASED 3 0.0001
392 COGNITIVE DISORDER 3 0.0001
393 THERAPY PARTIAL RESPONDER 1 0.0001
394 CYANOSIS 1 0.0001
395 PNEUMOTHORAX 1 0.0001
396 OBESITY 1 0.0001
397 MOOD SWINGS 2 0.0001
398 MULTIPLE SCLEROSIS 3 0.0001
399 SCIATICA 1 0.0001
400 HYPOTHYROIDISM 2 0.0001
401 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
402 SENSORY DISTURBANCE 1 0.0001
403 MOVEMENT DISORDER 2 0.0001
404 HIP FRACTURE 2 0.0001
405 RHINORRHOEA 4 0.0001
406 DYSPEPSIA 6 0.0001
407 OSTEONECROSIS 2 0.0001
408 STAPHYLOCOCCAL INFECTION 2 0.0001
409 HEART RATE INCREASED 6 0.0001
410 VENTRICULAR TACHYCARDIA 1 0.0001
411 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
412 VIRAL INFECTION 2 0.0001
413 FUNGAL INFECTION 2 0.0001
414 LEUKOPENIA 3 0.0001
415 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
416 ANGER 2 0.0001
417 FLUID RETENTION 3 0.0001
418 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
419 METRORRHAGIA 1 0.0001
420 GASTRIC DISORDER 2 0.0001
421 PARANOIA 1 0.0001
422 GAIT DISTURBANCE 11 0.0001
423 AMENORRHOEA 1 0.0001
424 HEART RATE DECREASED 2 0.0001
425 METASTASES TO LIVER 1 0.0001
426 HYPOXIA 2 0.0001
427 DEPRESSED MOOD 3 0.0001
428 SLEEP DISORDER 4 0.0001
429 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
430 HEAD DISCOMFORT 1 0.0001
431 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
432 CEREBRAL HAEMORRHAGE 2 0.0001
433 GOUT 1 0.0001
434 OSTEOMYELITIS 1 0.0001
435 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
436 PELVIC PAIN 1 0.0001
437 CRYING 2 0.0001
438 C-REACTIVE PROTEIN INCREASED 2 0.0001
439 MUSCLE SPASMS 10 0.0001
440 FEELING ABNORMAL 13 0.0001
441 DYSGEUSIA 4 0.0001
442 THINKING ABNORMAL 1 0.0001
443 SWELLING 5 0.0001
444 HALLUCINATION 4 0.0001
445 BLOOD SODIUM DECREASED 1 0.0001
446 FOOT FRACTURE 1 0.0001
447 PROTEINURIA 1 0.0001
448 NEUROPATHY PERIPHERAL 5 0.0001
449 MUSCULOSKELETAL DISORDER 1 0.0001
450 INCREASED APPETITE 1 0.0001
451 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
452 SEROTONIN SYNDROME 1 0.0001
453 DRUG PRESCRIBING ERROR 1 0.0001
454 ACUTE RESPIRATORY FAILURE 1 0.0001
455 GLAUCOMA 1 0.0001
456 DYSTONIA 1 0.0001
457 CHOKING 1 0.0001
458 BONE PAIN 3 0.0001
459 KIDNEY INFECTION 1 0.0001
460 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
461 SINUS DISORDER 1 0.0001
462 ABNORMAL BEHAVIOUR 2 0.0001
463 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
464 OEDEMA PERIPHERAL 6 0.0000
465 OSTEOPOROSIS 2 0.0000
466 INFLUENZA LIKE ILLNESS 4 0.0000
467 TOOTH LOSS 1 0.0000
468 ROAD TRAFFIC ACCIDENT 2 0.0000
469 KNEE ARTHROPLASTY 1 0.0000
470 DECREASED APPETITE 11 0.0000
471 EATING DISORDER 1 0.0000
472 RETCHING 1 0.0000
473 JOINT INJURY 1 0.0000
474 IMPAIRED WORK ABILITY 1 0.0000
475 HYPOAESTHESIA 7 0.0000
476 IRRITABLE BOWEL SYNDROME 1 0.0000
477 SKIN CANCER 1 0.0000
478 FATIGUE 36 0.0000
479 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
480 ALTERED STATE OF CONSCIOUSNESS 1 0.0000
481 MENTAL DISORDER 2 0.0000
482 CONSTIPATION 10 0.0000
483 INTENTIONAL PRODUCT MISUSE 4 0.0000
484 MELAENA 1 0.0000
485 BLOOD PRESSURE DECREASED 3 0.0000
486 TOOTH DISORDER 1 0.0000
487 INFLUENZA 5 0.0000
488 SOMNOLENCE 9 0.0000
489 ORAL PAIN 1 0.0000
490 RASH PAPULAR 1 0.0000
491 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
492 PARAESTHESIA 7 0.0000
493 THERAPY NON-RESPONDER 2 0.0000
494 HEART RATE IRREGULAR 1 0.0000
495 DRUG INTERACTION 7 0.0000
496 MUSCULAR WEAKNESS 5 0.0000
497 VISION BLURRED 6 0.0000
498 SUICIDAL IDEATION 4 0.0000
499 SKIN DISCOLOURATION 2 0.0000
500 SHOCK 1 0.0000
501 HYPOKALAEMIA 2 0.0000
502 PERICARDIAL EFFUSION 1 0.0000
503 CHEST PAIN 8 0.0000
504 WEIGHT DECREASED 12 0.0000
505 BURNING SENSATION 3 0.0000
506 PALPITATIONS 5 0.0000
507 PRODUCTIVE COUGH 2 0.0000
508 MOBILITY DECREASED 3 0.0000
509 BLOOD GLUCOSE DECREASED 2 0.0000
510 PRURITUS 16 0.0000
511 CONTUSION 4 0.0000
512 INTERSTITIAL LUNG DISEASE 2 0.0000
513 HYPOGLYCAEMIA 2 0.0000
514 FIBROMYALGIA 1 0.0000
515 EXTRAPYRAMIDAL DISORDER 1 0.0000
516 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
517 WEIGHT INCREASED 9 0.0000
518 HAEMATEMESIS 1 0.0000
519 FLUSHING 4 0.0000
520 HYPOPHAGIA 1 0.0000
521 HYPERHIDROSIS 5 0.0000
522 SKIN ULCER 1 0.0000
523 RASH GENERALISED 1 0.0000
524 VOMITING 18 0.0000
525 DEAFNESS 1 0.0000
526 PANCREATITIS 2 0.0000
527 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
528 THROMBOSIS 3 0.0000
529 FEAR 1 0.0000
530 THROAT TIGHTNESS 1 0.0000
531 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
532 OEDEMA 2 0.0000
533 LIMB INJURY 1 0.0000
534 PALLOR 1 0.0000
535 MOOD ALTERED 1 0.0000
536 TREATMENT NONCOMPLIANCE 2 0.0000
537 SKIN LESION 1 0.0000
538 MEMORY IMPAIRMENT 5 0.0000
539 CARDIAC ARREST 3 0.0000
540 HAEMATOCHEZIA 2 0.0000
541 ANAPHYLACTIC REACTION 2 0.0000
542 TREMOR 6 0.0000
543 MENTAL STATUS CHANGES 1 0.0000
544 ARTHROPATHY 2 0.0000
545 MEDICATION ERROR 2 0.0000
546 HAEMOPTYSIS 1 0.0000
547 NECK PAIN 2 0.0000
548 WOUND 1 0.0000
549 COUGH 10 0.0000
550 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
551 FLATULENCE 2 0.0000
552 DEPRESSION 8 0.0000
553 INTENTIONAL DOSE OMISSION 1 0.0000
554 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
555 ANGINA PECTORIS 1 0.0000
556 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
557 SEIZURE 4 0.0000
558 ASTHENIA 13 0.0000
559 ABDOMINAL PAIN 8 0.0000
560 LIVER FUNCTION TEST ABNORMAL 1 0.0000
561 DYSSTASIA 1 0.0000
562 DYSPHONIA 2 0.0000
563 DISEASE PROGRESSION 4 0.0000
564 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
565 RESPIRATORY DISORDER 1 0.0000
566 ADVERSE DRUG REACTION 3 0.0000
567 BLOOD POTASSIUM DECREASED 1 0.0000
568 CORONARY ARTERY DISEASE 1 0.0000
569 THERAPEUTIC RESPONSE DECREASED 2 0.0000
570 STOMATITIS 2 0.0000
571 ILL-DEFINED DISORDER 2 0.0000
572 PLEURAL EFFUSION 2 0.0000
573 VERTIGO 2 0.0000
574 DISCOMFORT 2 0.0000
575 DRUG ADMINISTRATION ERROR 1 0.0000
576 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
577 EMOTIONAL DISORDER 1 0.0000
578 RASH 14 0.0000
579 DIZZINESS 16 0.0000
580 BONE DENSITY DECREASED 1 0.0000
581 BLOOD GLUCOSE INCREASED 6 0.0000
582 LACTIC ACIDOSIS 1 0.0000
583 ATRIAL FIBRILLATION 3 0.0000
584 ALOPECIA 6 0.0000
585 EYE DISORDER 1 0.0000
586 HEADACHE 19 0.0000
587 GAIT INABILITY 1 0.0000
588 ABDOMINAL DISCOMFORT 5 0.0000
589 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
590 PRODUCT QUALITY ISSUE 4 0.0000
591 MYALGIA 5 0.0000
592 HEPATIC ENZYME INCREASED 2 0.0000
593 URINARY TRACT INFECTION 5 0.0000
594 CHEST DISCOMFORT 3 0.0000
595 HAEMATURIA 1 0.0000
596 ERYTHEMA 6 0.0000
597 NIGHTMARE 1 0.0000
598 ABDOMINAL DISTENSION 3 0.0000
599 HAEMORRHAGE 3 0.0000
600 RASH MACULAR 1 0.0000
601 HYPERTENSION 6 0.0000
602 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
603 DIARRHOEA 18 0.0000
604 PANIC ATTACK 1 0.0000
605 UNDERDOSE 2 0.0000
606 AGITATION 2 0.0000
607 DYSURIA 1 0.0000
608 PAIN IN EXTREMITY 8 0.0000
609 NASOPHARYNGITIS 5 0.0000
610 INJECTION SITE MASS 1 0.0000
611 FALL 9 0.0000
612 BRONCHITIS 2 0.0000
613 HOT FLUSH 2 0.0000
614 ARTHRALGIA 11 0.0000
615 CHRONIC KIDNEY DISEASE 2 0.0000
616 INCORRECT DOSE ADMINISTERED 6 0.0000
617 DIABETES MELLITUS 2 0.0000
618 BLOOD PRESSURE INCREASED 4 0.0000
619 CHILLS 3 0.0000
620 ARTHRITIS 2 0.0000
621 INJECTION SITE BRUISING 2 0.0000
622 INJECTION SITE HAEMORRHAGE 2 0.0000
623 EXTRA DOSE ADMINISTERED 1 0.0000
624 DRY MOUTH 2 0.0000
625 DYSKINESIA 1 0.0000
626 ANXIETY 7 0.0000
627 NAUSEA 19 0.0000
628 POLLAKIURIA 1 0.0000
629 SKIN EXFOLIATION 2 0.0000
630 OSTEOARTHRITIS 1 0.0000
631 RECTAL HAEMORRHAGE 1 0.0000
632 HYPOACUSIS 1 0.0000
633 SEPTIC SHOCK 1 0.0000
634 DYSPNOEA 13 0.0000
635 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
636 MUSCULOSKELETAL STIFFNESS 2 0.0000
637 DEHYDRATION 3 0.0000
638 COLITIS ULCERATIVE 1 0.0000
639 PULMONARY OEDEMA 1 0.0000
640 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
641 THROAT IRRITATION 1 0.0000
642 SKIN IRRITATION 1 0.0000
643 NEPHROLITHIASIS 1 0.0000
644 OROPHARYNGEAL PAIN 2 0.0000
645 BREAST CANCER 2 0.0000
646 DYSPHAGIA 2 0.0000
647 MIGRAINE 2 0.0000
648 DRUG INEFFECTIVE 27 0.0000
649 PYREXIA 7 0.0000
650 AGGRESSION 1 0.0000
651 HYPOTENSION 4 0.0000
652 CELLULITIS 1 0.0000
653 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
654 CONDITION AGGRAVATED 6 0.0000
655 PAIN 12 0.0000
656 HAEMOGLOBIN DECREASED 2 0.0000
657 ABDOMINAL PAIN UPPER 4 0.0000
658 INFLAMMATION 1 0.0000
659 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
660 NERVOUSNESS 1 0.0000
661 SPEECH DISORDER 1 0.0000
662 DERMATITIS ATOPIC 1 0.0000
663 PLATELET COUNT DECREASED 2 0.0000
664 DISTURBANCE IN ATTENTION 1 0.0000
665 MALAISE 8 0.0000
666 DRUG DOSE OMISSION 3 0.0000
667 SEPSIS 2 0.0000
668 URTICARIA 3 0.0000
669 OXYGEN SATURATION DECREASED 1 0.0000
670 HYPONATRAEMIA 1 0.0000
671 ASTHMA 2 0.0000
672 PRODUCT SUBSTITUTION ISSUE 1 0.0000
673 BACK PAIN 4 0.0000
674 SURGERY 1 0.0000
675 NASAL CONGESTION 1 0.0000
676 CATARACT 1 0.0000
677 IRRITABILITY 1 0.0000
678 JOINT SWELLING 2 0.0000
679 FEELING HOT 1 0.0000
680 INJECTION SITE PAIN 5 0.0000
681 HYPERSENSITIVITY 3 0.0000
682 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
683 VISUAL IMPAIRMENT 2 0.0000
684 LOSS OF CONSCIOUSNESS 2 0.0000
685 PNEUMONIA 5 0.0000
686 DEEP VEIN THROMBOSIS 1 0.0000
687 AMNESIA 1 0.0000
688 SWELLING FACE 1 0.0000
689 RENAL FAILURE 2 0.0000
690 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
691 INJECTION SITE REACTION 1 0.0000
692 DEVICE MALFUNCTION 1 0.0000
693 INJURY 1 0.0000
694 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
695 SKIN BURNING SENSATION 1 0.0000
696 RESPIRATORY FAILURE 1 0.0000
697 EPISTAXIS 1 0.0000
698 ACNE 1 0.0000
699 ACUTE KIDNEY INJURY 2 0.0000
700 INJECTION SITE SWELLING 1 0.0000
701 HOSPITALISATION 2 0.0000
702 PROSTATE CANCER 1 0.0000
703 CEREBROVASCULAR ACCIDENT 2 0.0000
704 TACHYCARDIA 1 0.0000
705 GASTROINTESTINAL DISORDER 1 0.0000
706 DEVICE ISSUE 1 0.0000
707 CARDIAC DISORDER 1 0.0000
708 ANAEMIA 2 0.0000
709 DRUG INTOLERANCE 1 0.0000
710 OFF LABEL USE 9 0.0000
711 SYNCOPE 1 0.0000
712 THROMBOCYTOPENIA 1 0.0000
713 RHEUMATOID ARTHRITIS 1 0.0000
714 PSORIASIS 1 0.0000
715 DRY SKIN 1 0.0000
716 NEUTROPENIA 1 0.0000
717 INFECTION 1 0.0000
718 PERIPHERAL SWELLING 1 0.0000
719 MYOCARDIAL INFARCTION 1 0.0000
720 PRODUCT USE ISSUE 1 0.0000
721 DEATH 4 0.0000
722 OVERDOSE 1 0.0000